Mettler Toledo Process Analytics Tech Note |
November 2018, MARIETTA, GA ~ Tissue engineering demands the utmost accuracy and repeatability from sensor measurements. A manufacturer of cutting-edge bioreactors for tissue applications has selected METTLER TOLEDO sensors for their performance and advanced features. The ex vivo engineering of living tissues is a young but rapidly developing field in the biotechnology industry. Tissue engineering utilizes human and animal cells, biomaterials, physical stimulation and biochemical factors to manipulate and grow tissue. Its applications are as wide ranging as replacement of animal testing during drug development to developing bioartificial human organs to creating edible artificial meat. Worldwide, the tissue engineering market is estimated to have grown from US $15 billion in 2014 to US $32 billion this year. Much of the development in tissue engineering requires advanced bioreactors that can standardize, control and automate the required growth and testing conditions in order to achieve high reproducibility.
At the forefront of bioreactor development
The company develops modular and scalable bioreactors that enable tissue production for a wide range of clinical and research applications. The bioreactors employ cloud computing and a web-based user interface to monitor and manage the tissue engineering and analyze the resulting data from the pH, DO and other sensors. |
METTLER TOLEDO - "the obvious solution"
Jan Saam, founder and CEO of Ospin, explains: "Our customers already use METTLER TOLEDO sensors in their biotech research and production, so selecting them for our bioreactors was the obvious solution for pH and DO measurement. Also, the digital output from METTLER TOLEDO pH and electrochemical DO ISM probes made integration into our applications easy."
Error-free installation
Pre-batch diagnostics
Future partnership
To Find out more about Mettler Toledo's Intelligent Sensor Management platform, please click here. |